Renal insufficiency and anticancer drugs in elderly cancer patients: A subgroup analysis of the IRMA study

Critical Reviews in Oncology/Hematology

Volumn 70, Issue 2, 2009, Pages 124-133

  Launay Vacher, Vincent ^a   Spano, Jean Philippe ^a   Janus, Nicolas ^a   Gligorov, Joseph ^b   Ray Coquard, Isabelle ^c   Oudard, Stéphane ^d   Pourrat, Xavier ^e   Morere, Jean François ^f   Beuzeboc, Philippe ^g   Deray, Gilbert ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL TENON   (France)

^c CENTRE LÉON BÉRARD   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e SERVICE DE DERMATOLOGIE   (France)

^f AVICENNE HOSPITAL   (France)

^g INSTITUT CURIE   (France)

Author keywords

Chemotherapy; Dosage adjustment; Elderly; Nephrotoxicity; Renal insufficiency

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CARBOPLATIN; CETUXIMAB; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; GEFITINIB; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; LETROZOLE; METHOTREXATE; MITOXANTRONE; NAVELBINE; OXALIPLATIN; PACLITAXEL; PAMIDRONIC ACID; RITUXIMAB; TAMOXIFEN; TOPOTECAN; TRASTUZUMAB; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; ZOLEDRONIC ACID;

AGED; AGING; ANEMIA; BONE METASTASIS; CANCER PATIENT; CLINICAL STUDY; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; FEMALE; FRANCE; GERIATRIC PATIENT; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; OBSERVATIONAL STUDY; PREVALENCE; QUALITY OF LIFE; REVIEW; SOLID TUMOR;

AGED; AGED, 80 AND OVER; ANTICARCINOGENIC AGENTS; CREATININE; FEMALE; FOOD HABITS; FRANCE; HEMOGLOBINS; HUMANS; MALE; NEOPLASMS; PREVALENCE; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES;

EID: 63249090524     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2008.09.012     Document Type: Review

References (16)

1. Matas A.J., Simmons R.L., Kjellstrand C.M., Buselmeier T.J., and Najarian J.S. Increased incidence of malignancy during chronic renal failure. Lancet 1 (1975) 883-886
2. Sutherland G.A., Glass J., and Gabriel R. Increased incidence of malignancy in chronic renal failure. Nephron 18 (1977) 182-184
3. Cengiz K. Increased incidence of neoplasia in chronic renal failure (20-year experience). Int Urol Nephrol 33 (2002) 121-126
4. Coresh J., Selvin E., Stevens L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 298 November 17 (2007) 2038-2047
5. Launay-Vacher V., Oudard S., Janus N., et al. Renal insufficiency and cancer medications (IRMA) study group. Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study. Cancer 110 6 (2007) 1376-1384
6. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(February Suppl 1):S1-266.
7. Levey A.S., Eckardt K.U., Tsukamoto Y., et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 67 (2005) 2089-2100
8. Cockcroft D.W., and Gault M.H. Prediction of CrCl from serum creatinine. Nephron 16 (1976) 31-41
9. Levey A.S., Greene T., Kusek J.W., et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11 (2000) 0828 [Abstract]
10. Verhave J.C., Fesler P., Ribstein J., du Cailar G., and Mimran A. Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis 46 August 2 (2005) 233-241
11. Aronoff G.R., Berns J.S., Brier M.E., et al. Drug prescribing in renal failure. Dosing guidelines for adults. 4th ed. (1999), American College of Physicians-American Society of Internal Medicine, USA
12. Launay-Vacher V., Karie S., and Deray G. GPR Anticancéreux. Guide de prescription des médicaments chez le patient insuffisant rénal. 3ème édition. (2005), Méditions International, France
13. Coresh J., Selvin E., Stevens L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 298 (2007) 2038-2047
14. Launay-Vacher V., Chatelut E., Lichtman S., Wildiers H., Steer C., and Aapro M. Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology (SIOG) clinical practice recommendations. Ann Oncol 18 (2007) 1314-1321
15. Nikolsky E., Mehran R., Lasic Z., et al. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 67 (2005) 706-713
16. Lichtman S., Wildiers H., Launay-Vacher V., Steer C., Chatelut E., and Aapro M. International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency. Eur J Cancer 43 (2007) 14-34